BackAnxo Pharmaceutical , Ltd. Overview

Anxo Pharmaceutical , Ltd. Profit Margin

Latest profit margin for Anxo Pharmaceutical , Ltd.: -3.56% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-1.50%
↑ 70.12% YoY

As of Jun 2026

Annual Profit Margin (TTM)

-3.56%
↓ 588.86% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Anxo Pharmaceutical , Ltd. (6677.TWO) FAQ

As of the most recent data (June 2026), 6677.TWO shows a profit margin of -3.56%. That compares with 0.73% in the prior-year period — down 588.9% year over year. That is below the sector sector average of 13.4%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6677.TWO's profit margin is now -3.56% (was 0.73%) — a 588.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Anxo Pharmaceutical , Ltd. is outperforming or lagging.

The its sector sector average profit margin is about 13.4%. Anxo Pharmaceutical , Ltd. is at -3.56%, which is lower that average. That is roughly 126.6% below the sector mean. Use the comparison chart on this page to see how 6677.TWO stacks up against individual peers as well.

That compares with 0.73% in the prior-year period — down 588.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Anxo Pharmaceutical , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Anxo Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -3.56%) with ownership activity and broader fundamentals.